The Importance of Access Management in Building a Secure Biostats Environment

In today’s fast-paced research environment, biostatistics teams play a critical role in drug development, as well as in nonclinical and clinical research. Their work directly impacts regulatory submissions, trial outcomes, and, ultimately, patient safety. However, as teams grow, managing secure and efficient access to study information and data within statistical computing environments (SCEs) becomes increasingly complex¹. Without proper access controls, teams risk data integrity breaches, compliance violations, and inefficiencies that slow down research and development².

This article explores the importance of robust access management and outlines strategies for securing study data while maintaining operational efficiency.

The Importance of Access Management in Biostats Teams

Access management is more than just assigning usernames and passwords. It is a fundamental component of data security and compliance that ensures the right people have the appropriate level of access to critical systems and data. Without structured access controls, biostats teams may face²:

• Security risks – Unauthorized access can lead to accidental data modifications, security breaches, or turncoats.
• Compliance failures – Regulatory frameworks such as 21 CFR Part 11 and Good x Practice (GxP) require controlled access and audit trails to track system activity^3,4.
• Operational inefficiencies – Poorly managed access can slow workflows, causing delays in project execution and regulatory submissions.
• Audit vulnerabilities – Lack of documented access controls and change tracking can result in audit failures, delaying approvals and increasing scrutiny from regulators⁵.

Consequently, for new and growing biostats teams, establishing a structured access management framework is essential to avoid these risks and maintain the integrity of their statistical analyses.

Building a Secure Access Management Framework

To safeguard sensitive study data and ensure compliance, biostats teams must implement a comprehensive access control strategy that includes:

1. Applying the Principle of Least Privilege

The principle of least privilege (PoLP) is a cybersecurity best practice that ensures users only have access to the data and applications that are absolutely necessary to perform their job functions⁶. This minimizes the risk of accidental or intentional data breaches.

To implement PoLP effectively, organizations should:

1. Regularly review and update user permissions as team structures evolve and team members are onboarded and offboarded.
2. Assign user roles based on job functions (e.g., biostatisticians, data managers, administrators).
3. Restrict access to sensitive data, such as unblinded clinical trial results, to only those who require it.

2. Implementing Role-Based Access Controls

Role-Based Access Control (RBAC) is an access management model that assigns permissions to users based on predefined roles. Instead of managing access at an individual level, RBAC simplifies administration by grouping users with similar responsibilities⁷.

Key benefits of RBAC include:

• Consistent access policies – Ensures team members have the correct permissions without excessive privileges.
• Simplified user management – New employees can be onboarded quickly with role-based permissions.
• Reduced security risks – Prevents unauthorized access by limiting permissions to only what is necessary.

For example, in a biostats team, an RBAC model might involve biostatisticians having read/write access to statistical software but no administrative rights, while data managers have access to data repositories but are restricted from modifying statistical models, and IT administrators having system-wide permissions for software installations and user management.

3. Enforcing Deny Groups for Sensitive Data

In addition to access permission control through RBAC setups, deny groups add an extra layer of protection by restricting access to highly sensitive data. This is particularly important in clinical research settings, where specific datasets (e.g., unblinded clinical trial data) must remain inaccessible to certain users to maintain the integrity of the study⁸.

For example, unblinded study data should be restricted to a select group of statisticians⁸. Moreover, IT staff responsible for system maintenance should not have access to confidential research data. By enforcing deny lists, organizations can prevent unauthorized access to specific datasets or study information, even if a user’s role would otherwise grant them broader permissions.

4. Automating Access Control Workflows

As biostats teams grow, manually managing access permissions becomes inefficient and error-prone. Automating access control workflows streamlines user management and ensures permissions are updated promptly when team members join, leave, or change roles⁹.

Automated workflows provide:

• Improved compliance tracking – Ensures all access changes are logged for audit readiness.
• Faster onboarding and offboarding – New employees receive immediate access to necessary tools, and leaving employees have their access revoked immediately.
• Reduced human error – Prevents the accidental provision of incorrect permissions or failure to revoke access for former employees.

Streamlining Access Management With Pre-Built Solutions

For new and growing biostats teams, implementing a secure access management framework from scratch can be time-consuming and resource-intensive. Pre-configured, cloud-based solutions offer a streamlined approach, reducing the administrative burden while ensuring compliance with the relevant regulations.

Accel™ is a pre-validated SCE designed for small to mid-sized biostats teams. It provides:

• Pre-configured role-based permissions, which ensure secure access control from day one.
• Automated access workflows to simplify onboarding and offboarding.
• Built-in audit trails in compliance with regulatory requirements.
• Centralized access management to eliminate inconsistencies across multiple systems.

By leveraging a pre-validated, cloud-based solution like Accel, biostats teams can achieve secure, efficient access management with minimal setup effort.

Conclusion

Access management is a key component of data security and regulatory compliance for biostats teams. Without proper controls, organizations risk data breaches, non-compliance, and operational inefficiencies that could put study integrity at risk. By implementing role-based access controls, deny groups, and automated workflows, teams can safeguard sensitive study data while maintaining a seamless workflow. Pre-built access management solutions like Accel simplify these processes, providing an efficient, compliant, and scalable approach for new and growing biostats teams.

Want to learn more? Download our full whitepaper to explore strategies for optimizing access management and other critical challenges faced by biostats teams. Or speak with an expert today to discuss how Accel can enhance your team’s security and efficiency.

References

1. Singh C, Thakkar R, Warraich J. IAM Identity Access Management—Importance in Maintaining Security Systems within Organizations. Eur J Eng Technol Res. 2023;8(4):30-38. doi:10.24018/ejeng.2023.8.4.3074

2. Seh AH, Zarour M, Alenezi M, et al. Healthcare Data Breaches: Insights and Implications. Healthcare. 2020;8(2):133. doi:10.3390/healthcare8020133

3. 21 CFR Part 11 — Electronic Records; Electronic Signatures. Accessed March 4, 2024. https://www.ecfr.gov/current/title-21/part-11

4. Good Clinical, Laboratory, and Manufacturing Practices (GxP) – Microsoft Compliance. February 1, 2024. Accessed January 14, 2025. https://learn.microsoft.com/en-us/compliance/regulatory/offering-gxp

5. Weiss RB, Tuttle SS. Preparing for Clinical Trial Data Audits. J Oncol Pract. 2006;2(4):157-159. doi:10.1200/jop.2006.2.4.157

6. Plachkinova M, Knapp K. Least Privilege across People, Process, and Technology: Endpoint Security Framework. J Comput Inf Syst. 2023;63(5):1153-1165. doi:10.1080/08874417.2022.2128937

7. Junior MA de C, Bandiera-Paiva P. Health Information System Role-Based Access Control Current Security Trends and Challenges. J Healthc Eng. 2018;2018:6510249. doi:10.1155/2018/6510249

8. Monaghan TF, Agudelo CW, Rahman SN, et al. Blinding in Clinical Trials: Seeing the Big Picture. Medicina (Mex). 2021;57(7):647. doi:10.3390/medicina57070647

9. Golightly L, Modesti P, Garcia R, Chang V. Securing distributed systems: A survey on access control techniques for cloud, blockchain, IoT and SDN. Cyber Secur Appl. 2023;1:100015. doi:10.1016/j.csa.2023.100015